CHANGE IN CONTROL AGREEMENTChange in Control Agreement • March 1st, 2011 • Allergan Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 1st, 2011 Company Industry JurisdictionThis Agreement (“Agreement”) dated as of [________________], is entered into by and between [________________] (“Employee”), and Allergan, Inc., a Delaware corporation (the “Company”), and amends, restates and supersedes the existing change in control agreement dated [________________], between Employee and the Company, in order to conform the terms of that agreement with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).
CO-PROMOTION AGREEMENTCo-Promotion Agreement • March 1st, 2011 • Allergan Inc • Pharmaceutical preparations
Contract Type FiledMarch 1st, 2011 Company IndustryThis Co-Promotion Agreement (this “Agreement”) is made and entered into effective as of January 28, 2011, by and between MAP Pharmaceuticals, Inc., a Delaware corporation having an address at 2400 Bayshore Parkway, Suite 200, Mountain View, California 94043 (“MAP”), and ALLERGAN USA, Inc., a Delaware corporation having an address at 2525 Dupont Drive, Irvine, California 92612 (“ALLERGAN”). MAP and ALLERGAN are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
COLLABORATION AGREEMENT BY AND AMONG MAP PHARMACEUTICALS, INC., ALLERGAN SALES, LLC, ALLERGAN USA, INC. AND ALLERGAN, INC. January 28, 2011Collaboration Agreement • March 1st, 2011 • Allergan Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 1st, 2011 Company Industry JurisdictionThis Collaboration Agreement (the “Agreement”) is made and entered into as of the 28th day of January, 2011 (the “Effective Date”) by and among MAP Pharmaceuticals Inc., a Delaware corporation having an address at 2400 Bayshore Parkway, Suite 200, Mountain View, California 94043 (“MAP”), Allergan USA, Inc., a Delaware corporation (“Allergan USA”), Allergan Sales, LLC, a California limited liability corporation (“Allergan Sales”), and Allergan, Inc., a Delaware corporation (collectively with Allergan USA and Allergan Sales, “ALLERGAN”), each having an address at 2525 Dupont Drive, Irvine, California 92612. MAP and ALLERGAN are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.